1 Min Read
* UNIT RECEIVED PERMISSION OF CLINICAL TRIAL GRANTED BY CHINA FDA WITH RESPECT TO LCAR- B38M CAR-T FOR AUTOLOGOUS INFUSION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.